Some commentary on Aduhelm and the crazy US health system.No...

Some commentary on Aduhelm and the crazy US health system.
No wonder Biogen wanted to rush this to market to rescue their business.
We are not under the same pressure.

https://www.theatlantic.com/ideas/archive/2021/06/aduhelm-drug-alzheimers-cost-medicare/619169/

"Earlier this week, the Food and Drug Administration overruled—to much criticism—its own scientific advisory committee and approved the Alzheimer’s treatment Aduhelm. The agency made this decision despite thin evidence of the drug’s clinical efficacy and despite its serious side effects, including brain swelling and bleeding. As a result, a serious risk now exists that millions of people will be prescribed a drug that does more harm than good."

https://www.fiercepharma.com/pharma/biogen-fda-aducanumab-decision

"For Biogen, the company's all-in bet on aducanumab, now marketed as Aduhelm, comes amid serious troubles elsewhere in its business. Multiple sclerosis drug Tecfidera and spinal muscular atrophy med Spinraza have been facing increasing competitive pressures, leading the company to post a sales decline in 2020."